Venlafaxine Hydrochloride
Product Images NDC 53002-2366

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 53002-2366). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530022366)

Venlafaxine Hydrochloride 37.5 mg ER-Capsules packaging label from RPK Pharmaceuticals, Inc. It shows a 30-capsule blister pack with instructions to take one capsule daily or as directed. The label includes prescription-only designation, lot number, expiration date, and placeholder spaces for patient and prescriber information, as well as the clinic name.*

FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

A pharmacokinetic interaction chart for venlafaxine highlighting the fold change in Cmax and AUC with various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The chart includes 90% confidence intervals and recommendations for concomitant use.*

FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

A pharmacokinetic chart illustrating the fold change in Cmax and AUC for various analytes when taken with interacting drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The graph also includes 90% confidence interval bars and recommendations for dose adjustment or caution.*

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

A chart depicting pharmacokinetic (PK) fold change and 90% confidence intervals for venlafaxine and its metabolite O-desmethylvenlafaxine (ODV) across special populations including hepatic impairment, renal impairment, CYP2D6 polymorphism, age, and gender. It correlates PK parameters Cmax and AUC with dose adjustment recommendations based on changes relative to reference values.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride showing its molecular arrangement including rings, functional groups, and hydrochloride salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.